This course is part of PrimaryCareNow: Live on May 14-15, 2026.
Generic Placeholder Website Image

Activity content starts in:

Industry Webcast

Agitation Associated With Dementia Due to Alzheimer’s Disease: Impact and Symptom Management Considerations In a Community SettingIndustry Webcast Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck; Not for CME/CE Credit

This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on patients living in the community setting. Participants will gain valuable insights on how healthcare providers can support caregivers in identifying signs of agitated behaviors. The program will also provide an overview of the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer’s disease.

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 5/14/2026

Expiration Date: 5/14/2026

Topics

Faculty

Faculty

Dung Trinh, MD

Learn More

Supporters and Partners

Industry Sponsor

Otsuka America Pharmaceutical, Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Agitation Associated With Dementia Due to Alzheimer’s Disease: Impact and Symptom Management Considerations In a Community Setting

Register